Head and Neck Cancer Diagnostics Market to be dominated by Diagnostic Imaging through 2027
The growing old age
population and advancements in head and neck cancer diagnostics technology are
augmenting the growth of the global head and neck cancer diagnostics market in
the forecast period, 2023-2027.
According to TechSci Research report, “Head and Neck Cancer Diagnostics Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2017-2027”, the global head and neck cancer diagnostics market
is anticipated to witness a growth of steady CAGR in the forecast period,
2023-2027. Head and Neck cancer can be defined as the numerous types of
malignant tumors grown around the head and neck. They begin in squamous cells
that line the mucosal surface of the head and neck, which is referred to as
squamous cell carcinoma. This cancer is among the ten most common types of
cancers worldwide and is especially prevalent in regions where alcohol and
tobacco consumption are high.
The global head and neck
cancer diagnostics market is expected to grow in the upcoming years at a rapid
rate. The growing number of cases of chronic diseases and the rising number of
diagnostic procedures for head and neck cancer are among the primary factors
driving the global head and neck cancer diagnostics market. Along with this,
government bodies and various private organizations are taking healthcare
initiatives to make people aware people about the preventive measures for
chronic diseases like head and neck cancer.
Head and neck cancers
usually affect the oral cavity, paranasal sinuses, pharynx, larynx, nasal
cavity, and salivary glands. At present, immunotherapy has been identified as
one of the effective techniques for cancer treatment. Numerous immunotherapies,
including immune checkpoint inhibitors, have been approved for head and neck
cancer treatment, augmenting the global head and neck cancer diagnostics
market.
However, the high cost
of the testing devices and unfavorable reimbursement of the oncological
treatment may restrain the market growth in the forecast period.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Global
Head and Neck Cancer Diagnostic Market"
https://www.techsciresearch.com/report/global-head-and-neck-cancer-diagnostic-market/10618.html
The global head and neck
cancer diagnostic market is segmented based on type, end user, company, and
regional distribution.
Based on the type, the
market is divided into diagnostic imaging, biopsy, endoscopy, and dental
diagnostics. Diagnostic imaging is projected to account for the highest market
share in the upcoming years. Increasing awareness about the benefits of early detection
of diseases is propelling the market growth. Increasing concern for the wellbeing
of a patient and the escalating demand for effective treatment procedures at
any cost is accelerating the growth of the head and neck cancer diagnostic
market. Numerous initiatives are being taken by the government bodies to lower
the cost of oncological treatment in hospitals.
Based on the end user, the
market is divided into hospitals, specialty clinics, ambulatory surgical
centers, and others. Hospitals are anticipated to capture the largest market
share in the forecast period. Hospitals offer required facilities to the
patients to treat the patients with quality care. Along with this, hospitals
focus on providing all kinds of diagnostic with advanced equipment and novel
technologies.
Based on regional analysis,
the North American region is expected to dominate the global head and neck
cancer diagnostic market in the forecast period. The early adoption of cancer
diagnostics technology by healthcare facilities and the rising number of cancer
cases across the United States are propelling the market growth. As per the
study done by the American Society of Clinical Oncology (ASCO) in January 2021,
head, and neck cancer accounted for about 4% of all cancer types in the United
States, which further bolsters the demand for diagnostic imaging in the region.
Leading market players
operating in the global head and neck cancer diagnostic
market are:
- Addent Inc
- GE Healthcare
- Koninklijke Philips NV
- Shimadzu Corporation
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Canon Medical system Corporation
- Carestream Healthcare Inc.
- Neusoft Medical Systems Co., Ltd.
- Varian Medical Systems, Inc.
Download
Sample Report@ https://www.techsciresearch.com/sample-report.aspx?cid=10618
Customers can also
request for 10% free customization on this report.
“Continuous technological advancements
and product innovations in diagnostic methodology are anticipated to stimulate
the global head and neck cancer diagnostic market. In addition to this,
extensive research funding by public and private organizations for oncological
advancement further supports the market growth. Early diagnosis and advanced
treatment facilities allow patients to cure diseases like head and neck
cancers, especially oral and pharyngeal cancers. Development of
immunotherapies, and CAR-T cell therapies, among others, for cancer treatment
and a large patient pool are expected to propel the global head and neck cancer
diagnostic market till 2027” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Head And Neck Cancer Diagnostic
Market - Global Industry Size, Share, Trends, Opportunity and Forecast,
2017-2027 Segmented By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental
Diagnostics), By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others), By Biopsy
(Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing), By Endoscopy
(Pharyngoscopy, Laryngoscopy, Panendoscopy), By Dental Diagnostics (Brush
Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue
Dye-Based Method), By End User (Hospitals, Specialty Clinics, Ambulatory
Surgical Centers, Others), and By Region”, has evaluated the future growth
potential of global head and neck cancer diagnostic market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global head and neck cancer diagnostic market.
Contact
Mr. Ken Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]